3.09
Finanzdaten der Armata Pharmaceuticals Inc-Aktie (ARMP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
33.93%
12.82
|
9.574 | 14.91 | 8.935 | 9.013 |
| Operating Income/Loss |
17.38%
-10.31
|
-8.785 | -13.82 | -7.776 | -6.844 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
164.28%
74.14
|
-115.35 | -124.30 | -26.68 | -16.30 |
| Basic Average Shares |
0.60%
36.75
|
36.53 | - | 36.23 | 36.19 |
| Diluted Average Shares |
69.84%
62.04
|
36.53 | - | 36.23 | 36.19 |
| Basic Earnings Per Share |
163.92%
2.02
|
-3.16 | - | -0.74 | -0.45 |
| Diluted Earnings Per Share |
91.46%
-0.27
|
-3.16 | - | -0.74 | -0.45 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):